Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat

Psychopharmacology

Volumn 133, Issue 4, 1997, Pages 372-377

  Kimmel, Heather L ^a   Tallarida, Ronald J ^b   Holtzman, Stephen G ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 OHDA; Buprenorhpine; Cocaine; Drug interactions; Isobologram; Rotational behaviour; Statistics; Substantia nigra; Synergism

Indexed keywords

BUPRENORPHINE; COCAINE;

ANIMAL MODEL; ARTICLE; BRAIN INJURY; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG INTERACTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BRAIN CHEMISTRY; BUPRENORPHINE; CATECHOLAMINES; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG SYNERGISM; MALE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; ROTATION; STEREOTYPED BEHAVIOR; SUBSTANTIA NIGRA;

EID: 0030819273     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050416     Document Type: Article

References (40)

1. Brown EE, Finlay JM, Wong JTF Damsma G, Fibiger HC (1991) Behavioral and neurochemical interactions between cocaine and buprenorphine: implications for the pharmacotherapy of cocaine abuse. J Pharmacol Exp Ther 256: 119-126
2. Carroll ME, Lac ST (1992) Effects of buprenorphine on self-administration of cocaine and a nondrug reinforcer in rats. Psychopharmacology 106: 439-446
3. Carroll ME, Carmona GN, May SA, Buzalsky S, Larson C (1992) Buprenorphine's effects of self-administration of smoked cocaine base and orally delivered phencyclidine, ethanol and saccharin in rhesus monkeys. J Pharmacol Exp Ther 261: 26-37
4. Compton PA, Ling W, Charuvastra VC, Wesson DR (1995) Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence. J Addict Dis 14: 97-114
5. Cowan A, Lewis JW, Macfarlane IR (1977) Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 60: 537-545
6. Crowley TJ, Williams EA, Mikulich SK, Ingersoll NC (1993) Buprenorphine and cocaine effects on social behavior of monkeys. Drug Alcohol Depend 31: 235-245
7. Di Chiara G, Imperato A (1988a) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc Natl Acad Sci USA 85: 5274-5278
8. Di Chiara G, Imperato A (1988b) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244: 1067-1080
9. Dykstra LA, Doty P, Johnson AB, Picker MJ (1992) Discriminative stimulus properties of cocaine, alone and in combination with buprenorphine, morphine and naltrexone. Drug Alcohol Depend 30: 227-234
10. Foltin RW, Fischman MW (1994) Effects of buprenorphine on the self-administration of cocaine by humans. Behav Pharmacol 5: 79-89
11. Garrett BE, Holtzman SG (1996) Comparison of the effects of prototypical behavioral stimulants on locomotor activity and rotational behavior in rats. Pharmacol Biochem Behav 54: 469-477
12. Hudson JL van Horne CG, Stromberg I, Brock S, Clayton J, Masserano J, Hoffer BJ, Gerhardt GA (1993) Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 626: 167-174
13. Iuvone PM, Boatright JH, Bloom MM (1987) Dopamine mediates the light-evoked suppression of serotonin N-acetyl-transferase activity in retina. Brain Res 418: 314-324
14. Jackson HC, Griffin IJ, Nutt DT (1993) Buprenorphine-cocaine interactions in mice: effect on locomotor activity and hole-dipping behavior. J Pharm Pharmacol 45: 636-640
15. Kalivas PW, Stewart T (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16: 223-244
16. Kamien TB, Bergman J, Madras BK, Spealman RD (1990) Buprenorphine potentiates behavioral effects of cocaine in squirrel monkeys. Fed Am Sec Exp Biol J 4: A593
17. Kimmel HL, Holtzman SG (1997) Mu opioid agonists potentiate amphetamine-and cocaine-induced rotational behavior in the rat. J Pharmacol Exp Ther 282
18. Kosten TR, Kleber HD, Morgan C (1989) Treatment of cocaine abuse with buprenorphine. Biol Psychiatry 26: 637-639
19. Leander JD (1987) Buprenorphine has potent kappa opioid receptor antagonist activity. Neuropharmacology 26: 1445-1447
20. Mannelli P, Janirir L, Tempesta E, Jones RT (1993) Prediction in drug abuse: cocaine interactions with alcohol and buprenorphine. Br J Psychiatry 163: 39-45
21. Mansour A, Fox CA, Akil H, Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18: 22-29
22. Mello NK, Lukas SE, Kamien JB, Mendelson JH, Drieze J, Cone EJ (1992) The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J Pharmacol Exp Ther 260: 1185-1193
23. Mello NK, Kamien JB, Lukas SE, Mendelson JH, Drieze JM, Sholar JW (1993a) Effects of intermittent buprenorphine administration on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 264: 530-541
24. Mello NK, Lukas SE, Mendelson TH, Drieze J (1993b) Naltrexone-buprenorphine interactions: effects on cocaine self-administration. Neuropsychopharmacology 9: 211-224
25. Negus SS, Dykstra LA (1988) κ-Antagonist properties of buprenorphine in the shock titration procedure. Eur J Pharmacol 156: 77-86
26. Negus SS, Picker MT, Dykstra LA (1990) Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure. Psychopharmacology 102: 465-473
27. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, New York
28. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MT (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223
29. Rosen MI, Pearsall HR, McDougle CJ, Price LH, Woods SW, Kosten TR (1993) Effects of acute buprenorphine on responses to intranasal cocaine: a pilot study. Am J Drug Alcohol Abuse 19: 451-464
30. Sander NT, Lendvai B, Vizi ES (1992) Effect of selective opiate antagonists on striatal acetylcholine and dopamine release. Brain Res Bull 29: 369-373
31. Silverman PB (1990a) Cocaine and local anesthetics: stimulant activity in rats with nigral lesions. Psychopharmacology 102: 269-272
32. Silverman PB (1990b) Direct dopamine agonist-like activity conditioned to cocaine. Pharmacol Biochem Behav 37: 231-234
33. 3H]dopamine release from rat ventral mesencephalic dissociated cell cultures. Mol Pharmacol 42: 575-583
34. Spealman RD, Bergman J (1992) Modulation of the discriminative-stimulus effects of cocaine by mu and kappa opioids. J Pharmacol Exp Ther 261: 607-615
35. Strain EC, Stitzer ML, Liebson IA, Bigeiow GE (1994) Comparison of buprenorphine and methadone in the treatment of opioid dependence. Am J Psychiatry 151: 1025-1030
36. Tallarida RJ (1992) Statistical analysis of drug combinations for synergism. Pain 49: 93-97
37. Tallarida RJ, Kimmel HL, Holtzman SG (1997) Theory and statistics of detecting synergism between two active drugs: cocaine and buprenorphine. Psychopharmacology 133: 378-382
38. Teoh SK, Mello NK, Mendelson JH Kuehnle J, Gastfriend DR, Rhoades E, Sholar W (1994) Buprenorphine effects on morphine- and cocaine-induced subjective responses by drug-dependent men. J Clin Psychopharmacol 14: 15-27
39. Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxydopamine induced denervation of the nigro-striatal dopamine system. Acta Physiol Scand 82: 69-93
40. Winger G, Skjoldager P, Woods JH (1992) Effects of buprenorphine and other opioid agonists and antagonists on alfentaniland cocaine-reinforced responding in rhesus monkeys. J Pharmacol Exp Ther 261: 311-317